Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atropine vs Glycopyrrolate for Bradycardia Prevention in Dexmedetomidine Sedation
NCT03322150Terminated
- Sponsor
- Yonsei University
- Start
- Oct 2017
- Primary completion
- Aug 2018
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
Randomised trial of atropine and glycopyrronium in bradycardia, sponsored by Yonsei University. Primary endpoints: Pulse rate and Blood pressure. Started Oct 2017; status: terminated.
02
Drugs
atropineglycopyrronium
03
Conditions
bradycardia
Beyond the preview
Go deeper on NCT03322150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03322150.